Position in XENE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$40,535,720
+$9,845,140 QoQ
Shares Held
671,566
+27.2% QoQ
Ownership
0.693%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#38
of 314 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in XENE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,813,568,275 across 424 Biotechnology names. XENE ranks #42 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in XENE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $40,535,720 | 671,566 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $30,690,580 | 527,783 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $19,663,158 | 438,714 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $20,000,600 | 498,147 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $15,335,121 | 489,940 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $2,718,352 | 81,024 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $2,578,693 | 65,783 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,708,892 | 43,406 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,826,758 | 46,852 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,086,632 | 48,470 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $2,854,382 | 61,971 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $2,362,743 | 69,167 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,521,094 | 65,483 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,183,296 | 61,003 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,374,355 | 60,217 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,837,164 | 50,891 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,460,037 | 47,996 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,368,801 | 44,776 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,580,617 | 50,596 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $578,346 | 37,850 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $832,703 | 44,721 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $905,058 | 50,562 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $717,045 | 46,622 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $690,246 | 62,353 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $772,900 | 61,635 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $664,512 | 58,599 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||